Latest On-Demand Webinars & Online Events

With the rapid increase in the development of oligonucleotide therapeutics and gene therapies, workflows for the identification, characterization and quantification of full-length products, their impurities and metabolites, are critical.

Psychedelics have been used for millennia in both spiritual and medicinal contexts. Recently, a number of clinical successes with psychedelics have generated considerable excitement; nevertheless, mechanisms underlying their therapeutic efficacy are largely unknown.

In drug development, microphysiological systems (MPS) are utilized to develop in vitro biological models that can generate more physiologically- and human-relevant data.

Vanderbilt University Medical Center researchers Robert Carnahan and Pavlo Gilchuk are attempting to compress the timeline for therapeutic antibody development, by integrating a series of advances in single-cell messenger RNA sequence analysis, bioinformatics, synthetic biology and high-throughput functional analysis.

Selection of the appropriate techniques and assays, and their application in well-managed analytical programs, can simplify the process of deformulation and ensure a speedy route to market.

Surface contamination can be a major problem within many industries. It has been shown to lead to component failures, production issues, final product defects and often expensive warranty claims.

Surface contamination can be a major problem within many industries. It has been shown to lead to component failures, production issues, final product defects and often expensive warranty claims.

Most in vitro, well-plate biological experiments require a media change every day or two, with cyclic variations in nutrient and metabolite concentrations leading to physiologically unrealistic gene expression and metabolism.

This talk will describe using a combined experimental approach of gene expression profiling, exosome analysis, and high-content imaging in 2D and 3D liver cell culture models to evaluate early IDILI events and risk factors contributing to overt liver injury observed in the clinic.

In this session, Pall Corporation and Evello International will share their best practices on how to optimize your extraction and filtration process.